Key Insights On Using Hyperbaric Oxygen For Wounds
- Volume 23 - Issue 1 - January 2010
- 13170 reads
- 1 comments
Research has shown that HBOT is cost effective in comparison to amputation and increases quality of life years.8,9 Dr. Fife notes the cost benefit of HBOT is enhanced by proper patient selection. Patients are best referred before tissue loss has progressed to the point where amputation is inevitable, says Dr. Fife. She notes that transcutaneous oximetry can be useful in screening out patients who are likely to get well without HBOT or patients who cannot be helped.
Dr. Fife says one should not use HBOT as an alternative to proper revascularization. She says those on dialysis or those who have a transplant are less likely to benefit from HBOT, but are also less likely to benefit from any other intervention.
Dr. Fife maintains that HBOT must be under the supervision of a properly trained advanced care practitioner who can manage complications.
“When hyperbaric treatment is used in conjunction with standard wound care, researchers have demonstrated improved results in the healing of difficult or limb-threatening wounds in comparison to routine wound care alone,” she says.
Dr. DellaCorte is a Certified Hyperbaric Technologist. He is also a Fellow of the American College of Foot and Ankle Surgeons, and a Fellow of the American College of Foot and Ankle Orthopedics and Medicine. He is in private practice in Maspeth, N.Y.
Dr. Fife is an Associate Professor in the Department of Internal Medicine, Division of Cardiology at the University of Texas Health Science Center in Houston. She is the Director of Clinical Research at the Memorial Hermann Center for Wound Healing and Hyperbaric Medicine.
Dr. Suzuki is the Medical Director of Tower Wound Care Center at the Cedars-Sinai Medical Towers. He is also on the medical staff of the Cedars-Sinai Medical Center in Los Angeles and is a Visiting Professor at the Tokyo Medical and Dental University in Tokyo, Japan.
1. Carter MJ, Fife CE, Walker D, Thomson B. Estimating the applicability of wound-care randomized controlled trials to general wound care populations by estimating the percentage of individuals excluded from a typical wound care population in such trials. Adv Skin Wound Care 2009; 22(1):316-24.
2. Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. Diabetes Care 1996;19(12):1338-1343.
3. Mader JT, Shirtliff ME, Calhoun JH. The use of hyperbaric oxygen in the treatment of osteomyelitis. In: Hyperbaric medicine practice. Best Publishing Co., Flagstaff, Arizona, 1999, pp. 603-616.
4. Zamboni WA. Applications of hyperbaric oxygen therapy in plastic surgery. In: Oriani G, Marroni A, Wattel F, eds. Handbook on hyperbaric oxygen therapy. Springer-Verlag, New York, 1996.
5. Fife CE, Smart DR, Sheffield PJ, Hopf HW, Hawkins G, Clarke D. Transcutaneous oximetry in clinical practice: consensus statements from an expert panel based on evidence. Undersea Hyperb Med 2009; 36(1):43-53.
6. Fife CE, Buyukcakir C, Otto GH, Sheffield PJ, Warriner RA, Love TL, Mader J. The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy; a retrospective analysis of 1144 patients. Wound Rep Regen 2002; 10(4):198-207.
7. Fife CE, Buyukcakir C, Warriner R, Sheffield P, Love T, Otto G. Factors influencing the outcome of lower extremity of diabetic ulcers treated with hyperbaric oxygen therapy. Wound Repair Regen 2007; 15(3):322-331.
8. Cianci P, Petrone G, Drager S, Lueders H, Lee H, Shapiro R. Salvage of the problem wound and potential amputation with wound care and adjunctive hyperbaric oxygen therapy: an economic analysis. J Hyperbaric Med 1988; 3:127-141.
9. Guo S, et al. Cost effectiveness of adjunctive hyperbaric oxygen in the treatment of diabetic ulcers. Int J Technol Assess Health 2003; 19(4):731-737.